Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg-negative chronic hepatitis B and without cirrhosis.
Meng-Lan WangFa-Da WangEn-Qiang ChenPublished in: Alimentary pharmacology & therapeutics (2022)